Baricitinib: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "==Background== * Oral JAK inhibitor * Indications include COVID-19 ==Dosing== * 4 mg p.o. daily for 14 days, or until hospital discharge ===Renal Dosing=== * eGFR 30-60..." |
(No difference)
|
Revision as of 22:58, 13 January 2022
Background
- Oral JAK inhibitor
- Indications include COVID-19
Dosing
- 4 mg p.o. daily for 14 days, or until hospital discharge
Renal Dosing
- eGFR 30-60 mL/min: 2 mg p.o. daily
- eGFR 15-30 mL/min: 1 mg p.o. daily
